Ondine Biomedical (LON:OBI) Trading Down 2.2% – Here’s What Happened

Ondine Biomedical Inc. (LON:OBI) shares were down 2.2% during mid-day trading on Wednesday . The company traded as low as C$11.00 and last traded at C$11.00. 46,746 shares changed hands during trading, a decline of 90% from the average daily volume of 478,226 shares. The stock had previously closed at C$11.25.

Ondine Biomedical Stock Performance

The stock has a market cap of C$5.46 billion, a price-to-earnings ratio of -1.75 and a beta of 0.31. The stock’s 50-day moving average is C$13.04 and its 200-day moving average is C$12.76. The company has a debt-to-equity ratio of 11.85, a current ratio of 1.23 and a quick ratio of 8.26.

Ondine Biomedical Company Profile

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target.

Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.